BIOCHEMICAL MARKERS OF INFLAMMATION IN TUBERCULOSIS PATIENTS FROM TRIBAL AND NON-TRIBAL COMMUNITIES OF UDAIPUR REGION
DOI:
https://doi.org/10.22159/ajpcr.2025v18i6.54439Keywords:
Tuberculosis, Inflammation, C-reactive protein, Tumor necrosis factor-alpha, Interleukin-6, Tribal communities, Non-tribal communities, Rural IndiaAbstract
Objective: Tuberculosis (TB) continues to pose a serious health threat, especially in rural parts of India. Inflammation is a key to how TB develops and progresses. Tracking certain blood markers – such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) – can help us understand how severe the disease is and predict how it might unfold. This study looks at the levels of these markers in TB patients from tribal and non-tribal backgrounds in rural India.
Methods: We conducted a cross-sectional study involving 150 TB patients – 75 from tribal and 75 from non-tribal communities. Blood samples were analyzed using enzyme-linked immunosorbent assay to measure CRP, TNF-α, and IL-6 levels. We also gathered clinical and demographic data, including symptoms, disease duration, and treatment details. We compared inflammatory marker levels across groups using statistical analysis.
Results: TB patients from tribal communities had notably higher levels of CRP, TNF-α, and IL-6 than those from non-tribal groups (p<0.05). These elevated levels were also linked to more severe symptoms and longer treatment durations. Interestingly, females showed higher levels of these markers compared to males across both communities.
Conclusion: Our findings suggest that TB patients from tribal areas may experience a stronger inflammatory response, which could be tied to delays in diagnosis or treatment. There’s a clear need for early intervention and better access to care in these underserved regions to improve outcomes and reduce TB’s impact.
Downloads
References
Raviglione MC, O’Brien R, Kochi A. Tuberculosis and its control: Challenges and opportunities. Glob Health Action. 2018;11(1):1455063.
Chatterjee M, Das S, Khandelwal S, Singh A, Roy P, Verma N, et al. Inflammatory cytokines and their association with disease severity in tuberculosis patients. Indian J Tuberc. 2019;66(4):445-50.
Rao BS, Narayanasamy M, Nair N, Gupta R, Mehta S, Sharma K, et al. Prevalence of tuberculosis in rural tribal populations in India: An epidemiological study. Indian J Tuberc. 2016;63(3):171-5.
Chandra A, Kumar M, Banerjee G, Singh R, Patel D, Joshi L, et al. Gender differences in the immune response to tuberculosis: A study of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 levels in rural and tribal populations of India. J Infect Dis Ther. 2021;9(5):1000127.
Fatima N, Shameem M, Nabeela KH. Cytokines as biomarkers in the diagnosis of MDR TB cases. EC Pulmonolrespir Med. 2016;2(1):57-61.
Khandelwal S, Sharma S, Ghosh S, Verma A, Singh P, Rao N, et al. Comparison of inflammatory cytokines in tuberculosis patients from tribal and non-tribal populations in India. Indian J Infect Dis. 2017;45(2):108-13.
Yamada T, Nakajima Y, Takahashi Y, Matsuura E, Hirata S, Ueno K. Serum CRP levels in pulmonary tuberculosis and their correlation with disease severity. Chest. 2013;144(4):1232-8. doi: 10.1378/ chest.13-0196
Mukherjee A, Chandra N. Serum cytokine profile and their diagnostic utility in tuberculosis. Indian J Clin Biochem. 2020;35(4):490-6. doi: 10.1007/s12291-019-00852-2
Rathi S, Verma S, Pandey P. Role of CRP in tuberculosis: A review. Int J Res Med Sci. 2017;5(4):1306-11.
Möller M, Van Der Merwe L, Botes M, Walzl G, Malherbe S, Dheda K, et al. Gender differences in inflammatory cytokine levels in tuberculosis: Implications for treatment outcomes. BMC Infect Dis. 2018;18(1):155.
Pettengill MA, Filler R, Daniels R, Harding CV, Mendez D, Noyola DE, et al. Gender differences in immune responses to tuberculosis: A review of the literature. Trop Med Infect Dis. 2020;5(3):130.
Agarwal A, Shrivastava S, Sinha S, Patel R, Tiwari A, Rathi P, et al. Health disparities in rural India: Tribal health problems. J Health Disparities Res Pract. 2020;13(1):1-8.
Beig TY, Khan UH, Ganie BA, Tahir S, Shah S, Dhobi GN. Correlation between serum tumor necrosis factor-alpha (TNF-α) and clinical severity of tuberculosis: A hospital-based study. Cureus. 2023;15(2):e35626. doi: 10.7759/cureus.35626, PMID 37007342
Gupta P, Singh P, Das A, Kumar R. Determinants of tuberculosis: An example of high tuberculosis burden in the Saharia tribe. Front Public Health. 2023;11:1226980. doi: 10.3389/fpubh.2023.1226980, PMID 37920577
Published
How to Cite
Issue
Section
Copyright (c) 2025 Jain Suman
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
